Earnings Feed
Start Free
Home/Filings/4/0001349929-16-000118
4//SEC Filing

CANCER GENETICS, INC 4

Accession 0001349929-16-000118

CIK 0001349929operating
View on SEC.govCompany Profile

Filed

Oct 12, 8:00 PM ET

Accepted

Oct 13, 4:30 PM ET

Size

8.5 KB

Accession

0001349929-16-000118

Insider Transaction Report

Form 4
Period: 2016-10-11
CANCER GENETICS, INCCGIX
Chaganti Raju S.K.
Director
Transactions
  • Award

    Stock Option (right to buy)

    2016-10-11$1.81/sh+10,000$18,100→ 10,000 total
    Exercise: $1.81From: 2017-10-11Exp: 2026-10-11→ Common Stock, par value $0.0001 per share (10,000 underlying)
  • Award

    Common Stock, par value $0.0001 per share

    2016-10-11+2,500→ 139,071 total
Holdings

  • Common Stock, par value $0.0001 per share

    (indirect: By Spouse)
    161,322

  • Common Stock, par value $0.0001 per share

    (indirect: By limited liability company)
    60,000
Footnotes (2)
  • [F1]The restricted stock underlying the award vests in two equal installments on October 11, 2017 and October 11, 2018, respectively.
  • [F2]The option vests in two equal installments on October 11, 2017 and October 11, 2018, respectively.

Documents

1 file

Issuer

CANCER GENETICS, INC

CIK 0001349929

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001349929

Filing Metadata

Form type
4
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 4:30 PM ET
Size
8.5 KB
View on SEC.gov